Agenus News and Activities

Agenus is one of the...

• Russell 3000;
• TOB Iconic 10,000.

Agenus is a company listed under the stock ticker AGEN (US).

They are in:

• Pharmaceuticals50%
• Biotechnology50%

View the org chart displaying its 30 main executives

Most searched biographies at Agenus

• Garo Armen, Chairman of the Board & Chief Executive Officer
• Brian Corvese, Director
• Timothy Wright, Director

Popular executive movements at Agenus

• Tom Harrison has joined the company as Director  (posted on August 8 2024).

Create your alert
to follow the executive moves at Agenus.

Agenus has 1,828 competitors including Pfizer (United States (USA)), Sanofi (France) and Eli Lilly (United States (USA)).

Popular M&A news in Pharmaceuticals

• Chimerix and Chimerix have merged  (posted on April 22 2025)..
• Imbria Pharmaceuticals has just announced a $58 Million fundraising (posted on April 10 2025).
• Clario has acquired NRx Pharmaceuticals (posted on March 18 2025).

Popular contacts in Pharmaceuticals

• Estelle Vester-Blokland - Senior Vice President, Medical and Head, International Markets at Bristol-Myers Squibb
• Kristin Berkinsky - Chief Human Resources Officer at Adare Pharmaceuticals
• Seth Harrison - Chairman and Director at Braeburn Pharmaceuticals

Learn more about the Pharmaceuticals industry

Press releases by Agenus

• Agenus to Participate at BTIG Biotechnology Conference - Agenus Inc.
• Agenus Announces First Patient Dosed in Phase 1 Study of AGEN1571 (anti-ILT2) in Advanced Solid Tumors - Agenus Inc.
• Agenus to Provide Corporate Update and Second Quarter 2022 Financial Report - Agenus Inc.
• Agenus to Participate at William Blair’s Biotech Focus Conference - Agenus Inc.
• Agenus Shows Unprecedented Activity for Botensilimab/Balstilimab Combination in Microsatellite Stable Colorectal Cancer at ESMO World GI Congress - Agenus Inc.
• Agenus to Host Investor Webcast to Review Late-Breaking Botensilimab and Balstilimab Data Presented at ESMO World GI Congress - Agenus Inc.
• GSK’s RSV vaccine candidate for older adults, containing Agenus’ QS-21 STIMULON™ as part of GSK’s AS01 adjuvant, reports positive pivotal data supporting initiation of global regulatory submissions - Agenus Inc.
• Agenus Advances Portfolio with 6 Clinical Collaborations - Agenus Inc.
• Agenus Announces Virtual Annual Shareholders Meeting - Agenus Inc.
• Agenus to Participate at Jefferies Healthcare Conference - Agenus Inc.
• View more press releases Close

Social media about Agenus

• Agenus on Wikipedia, Google News & Yahoo Finance
• Agenus on LinkedIn, Twitter & YouTube